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Surface-enhanced Raman spectrocopy (SERS) offers ultrasensitive vibrational  fingerprinting at the nanoscale. Its non-
destructive nature affords an ideal tool for interrogation of the intracellular environment, detecting the localisation of 
biomolecules, delivery and monitoring of therapeutics and for characterisation of complex cellular processes at the 
molecular level. Innovations in nanotechnology have produced a wide selection of novel, purpose-built plasmonic 
nanostructures capable of high SERS enhancement for intracellular probing while microfluidic technologies are being 
utilised to reproducibly synthesise nanoparticle (NP) probes at large scale and in high throughput. Sophisticated  
multivariate analysis techniques unlock the wealth of previously unattainable biomolecular information contained within 
large and multidimensional SERS datasets. Thus, with suitable combination of experimental techniques and analytics, SERS 
boasts enormous potential for cell based assays and to expand our understanding of the intracellular environment. In this 
review we trace the pathway to utilisation of nanomaterials for intracellular SERS. Thus we review and assess nanoparticle 
synthesis methods, their toxicity and cell interactions before presenting significant developments in intracellular SERS 
methodologies and how identified challenges can be addressed.  
Introduction 
  Nanostructures such as carbon nanotubes, graphene, 
quantum dots, and nanomaterials made out of metals, 
semiconductors, non-metallic oxides and polymers have been 
developed for numerous biomedical applications including 
targeted delivery of drugs and genes, bioimaging, biosensing, 
and cancer treatment. Of particular interest are plasmonic 
nanoparticles (NPs), primarily of gold (Au) and silver (Ag), 
owing to their unique optical properties which allow intense 
scattering of light to achieve quantification, localisation and 
therefore imaging of biological systems
1
 down to the 
molecular level.  
  Surface-enhanced Raman spectroscopy (SERS), potentiated 
by noble metal nanostructures, was first observed in 1973 and 
subsequently verified in 1977, when the spontaneous Raman 
signal of adsorbed pyridine was easily measured at a 
roughened silver electrode
2–4
. The heightened intensities 
observed in SERS relative to spontaneous Raman spectroscopy 
are primarily due to the enhanced electric fields produced by 
conductance electrons at nanomaterial surfaces, which 
undergo collective oscillations known as surface plasmons. 
Combination of this electromagnetic mechanism with 
additional pathways such as charge transfer and 
chemisorption induced resonance Raman effects result in 
enhancement by factors of 10
6
-10
10
 in SERS
5,6
 over 
spontaneous Raman spectroscopy. Such enhancement is 
crucial to studies of intact and living cells as the concentrations 
of biomolecules inside cells are typically of the order of nM. It 
allows fine spectral details to be observed without 
interference from the vibrational peaks of H2O observed in IR 
spectroscopy. (Surface-enhanced) Raman spectroscopy also 
proves advantageous as it is a non-destructive and label-free 
tool with simple or no preparation of samples, utilising an 
increased depth of penetration by NIR radiation. Currently, 
fluorescence imaging is commonplace and  benefits as an 
intracellular technique from large intrinsic signals, availability 
of a wide range of labels (including a large palette of 
fluorescent proteins which can be incorporated endogenously 
through genetic modification) and the ability to tune the 
response of labels to analytes or pH
7
. However, it lacks the 
specificity of information provided by SERS, as only a finite 
number of dyes can be simultaneously employed for probing 
the desired environment due to spectral overlap. Such tagging 
of molecules can also perturb the natural, molecular-level 
progression of biological pathways being analysed
8
. It is worth 
noting that prolonged exposure to nanoparticles can also play 
an active role in mediating biological effects
9,10
. However, 
fluorescence has further limitations that signals get 
photobleached over time
8
 compared to Raman-based 
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techniques. Given that SERS has been shown to possess single 
molecule sensitivity
11–13
 and can be comparable or more 
sensitive than fluorescence for biological assays
14,15
 it offers 
numerous advantages and complimentary information for 
intracellular analysis. 
  For successful cellular investigations by SERS, however, the 
selection of suitable NPs is essential, which must overcome 
issues such as internalisation and toxicity while maintaining 
desired optical properties. For in cellulo studies, particle 
diameter must be small enough to penetrate the intracellular 
matrix yet larger than 15 nm to achieve SERS enhancement
16
. 
Spherical AgNPs exhibit stronger plasmonic fields than those of 
Au, especially in the visible region of the electromagnetic 
spectrum owing to the partial Au plasmon band overlap with 
its interband electronic transitions. Notwithstanding this, 
AuNPs are more widely applied in biological studies due to 
their well established and controlled methods of synthesis 
along with good biocompatibility and chemical stability. The 
ability to track and detect plasmonic NPs using various 
analytical tools, especially their localised surface plasmon 
resonance bands, which can be synthetically tuned into the 
near infrared region (the optical transparency window for 
biological tissues), is an added advantage.  Facile surface 
chemistry allows for easy surface functionalisation, affording 
not only the binding of specific delivery peptides, but also 
other applications such as artificial antibodies with binding 
affinities precisely tuned by varying the density of surface 
bound ligands. The ability to shield unstable drugs or poorly 
soluble imaging contrast agents to facilitate their delivery to 
otherwise inaccessible regions of the body is augmented by 
AuNPs’ multivalent nature
17
. 
  From the above it can thus be seen that the type of 
nanoparticles, choice of their surface chemistry and 
consequent interaction with cells (uptake, toxicity) can be 
critical to their utilisation for intracellular SERS. Through this 
review we therefore aim to provide an insight into all aspects 
involving intracellular SERS sensing and imaging. We trace all 
the steps involved in the use of nanostructures for intracellular 
SERS, starting with an evaluation of the main synthetic 
methods and different types of nanoparticles. While spherical 
AuNPs are currently the most widely used and understood, 
AgNPs have been used and alternative structures are 
becoming popular and will be discussed where relevant. This 
will be followed by an overview of crucial NP-cell interactions. 
Physical and diffusive routes of particle internalisation are 
examined along with biocompatibility factors such as tunability 
of surface properties for internalisation and resulting toxicity. 
The two prevalent approaches, the SERS-reporter and 
reporter-free approaches, to intracellular SERS are then 
presented. State-of-the-art and recent significant studies are 
discussed and the potential of intracellular SERS for numerous 
applications in life sciences, therapeutics and drug discovery is 
offered. 
Nanoparticle Synthesis 
  The earliest description of obtaining colloidal Au can be 
traced to ancient Chinese, Arabian, and Indian treatises dating 
back to as early as 4-5th BCE wherein it was utilised mostly for 
medicinal purposes
18,19
. However, it was Michael Faraday’s 
recognition that the properties of pure colloidal (or ‘activated’) 
Au, following its synthesis by reduction of Au chloride by 
phosphorus in the presence of carbon disulphide as a 
stabiliser, were due to its minute size,
20
 which attracted 
renewed scientific attention. With the wide availability of 
nanoscale characterisation tools, the design of AuNPs with 
precisely controlled sizes and shapes has since been 
comprehensively developed.  
    Depending upon the desired application, a variety of AuNP 
structures can be synthesised, ranging from nanospheres to 
nanowires, nanorods (NRs) with high aspect ratios, nanocages 
with a hollow interior and top down deposited nanochips. The 
size of AuNPs can also be precisely tuned from a few to 
hundreds of nm
1,17
. Figure 1 summarises several 
representative synthetic methods for preparation of AuNPs 
with controllable size and shape. Monodisperse Au 
nanospheres with 16-250 nm diameters can be synthesized via 
a citrate-mediated growth method, which was first 
demonstrated by Turkevich et al. in 1951
21
 and later 
systematically studied and improved by Frens
22
 (Figure 1B). A 
“necklace breaking” mechanism is typically involved in which 
small nuclei (5 nm in diameter) first assemble into chains, 
which interconnect and grow thicker. AuNPs eventually 
B 
A 
Figure 1 Representative synthetic approaches to prepare AuNPs with controllable size 
and shape. (A) Surfactant-mediated solution-based growth method to prepare AuNPs 
with hexagonal (A, I), cubic (A, II), rectangular (A, III), star (A, IV), dog bone (A, V), and 
rod (A, VI) shapes. (B) Citrate-mediated growth method to prepare Au nanospheres via 
direct reduction of Au ions. (C) Sequential growth method to prepare Au nanoshell on 
silica. (D) Galvanic replacement reaction on the surface of Ag nanocubes to prepare 
porous/hollow Au nanocages. Reprinted with permission from Alkilany et al. Acc. Soc. 
Res. 2013, 46, 650-661. Copyright (2013) American Chemical Society. Images in A and D 
are reprinted with permission from references 25 and 35 respectively; Copyright (2004, 
2011, respectively) American Chemical Society. Images in C is reprinted with permission 
from Wang et al. Acc. Chem. Res. 2007, 40, 5362; Copyright (2007)
 
American Chemical 
Society. 
D 
C 
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dissociate from these to generate monodisperse Au 
nanospheres
23
. Murphy et al. later established a surfactant-
mediated wet chemical growth method, allowing variation of 
the morphology and dimensions of AuNPs by adjusting 
reaction conditions
24,25
 (Fig. 1A). This method mixes pre-
synthesised single crystal Au seeds with aqueous growth 
solutions containing appropriate quantities of 
cetyltrimethylammonium bromide (CTAB), HAuCl4, ascorbic 
acid, and AgNO3. The fine control of NP morphology, such as 
NRs
26
, nanocubes
27,28
, nanotriangles
29
 and nanostars
30–32
 can 
be achieved by systematically varying the synthetic 
parameters. Generally, most wet-chemistry methods for the 
synthesis of NPs follow a similar protocol which is still widely 
used, in which solvated metal salt is reduced in the presence 
of stabilising surfactants and/or ligands. However, it is to be 
noted that NP growth and the subsequent control of NP 
morphology and size is a complex process strongly influenced 
by reaction kinetics, thermodynamics and stabilisation effects. 
Therefore, small changes in reaction parameters can often 
result in very different products.  
  Wet-chemistry methods such as the above provide AuNPs 
with a whole library of morphologies and sizes available not 
only for various biomedical applications, but also as building 
blocks for fabrication of further nanostructures. For example, 
Au nanoshells have attracted much attention due to their 
interesting plasmonic properties and exciting applications. 
Halas et al. developed a sequential growth method for 
achieving a better control over monodispersity of both the 
silica core and the Au nanoshell with both high purity and high 
yield
33
. The ultrasmall (1-2 nm in diameter) AuNPs were first 
anchored onto silica NP cores, followed by further reduction to 
form a complete Au shell layer (Fig. 1C). The thickness of Au 
shell layers is precisely tuned by varying the amount of Au 
deposited on the surface of the silica-core NPs. Silica-shell Au 
core NPs have also been recently developed for SERS based 
nanosensors. Tian et al. designed AuNPs coated with an 
ultrathin (2 nm) shell of silica or alumina
34
, preventing 
uncontrolled AuNP aggregation while retaining strong optical 
enhancement. In addition, the chemically inert and fully 
enclosed shell layer allows particles to adjust its conformation 
to the diverse contours of non-flat samples such as single-
crystal edges and biological cells. Au nanocages developed by 
Xia et al. possess unique cargo-holding hollow structures in 
addition to attractive optical properties, thus are useful for 
many biomedical applications, including bioimaging, cancer 
diagnosis, photothermal therapy, and drug delivery
35
 (Fig. 1D). 
In this approach, porous/hollow Au nanocages were obtained 
via a previously established galvanic replacement reaction
36–38
 
of Ag nanocubes with HAuCl4 at their surface. 
  Most syntheses reviewed here provide fairly simple and low 
cost, yet high yield synthetic routes for the fabrication of 
AuNPs with different morphologies and tunable sizes. 
However, most of them are conducted in a batch format, 
usually producing small quantities (<1 g) with multiple steps 
and poor inter-batch reproducibility. Simply scaling up the 
reactant volumes does not necessarily result in the same 
reaction scheme, because nucleation and growth of colloids 
are very complex processes that are extremely sensitive to 
experimental conditions. Implementing continuous and 
automated NP production processes is therefore desirable to 
facilitate scale up and improve homogeneity.  
  Xia et al. showed that by using microfluidic droplet reactors, 
continuous-flow mass production of a number of noble-metal 
NPs with controlled sizes and shapes can be achieved
39
. In this 
method, microlitre-sized droplets containing various reagents 
were continuously generated in a fluidic device fabricated by 
assembling silica capillaries inside polymer tubes. Microfluidic 
techniques are operated at a steady state, offering superior 
control over reaction conditions such as reagent addition, 
mixing, reaction time and temperature. NP size depends upon 
relative reaction and mixing rates along with the extent of 
polydispersity, enhanced by the improved control over heat 
and mass transport which accompanies the technology
39
. The 
approach also lends itself to accurate and rapid screening of 
conditions for quality control purposes. 
 Microfluidic AgNP synthesis has been performed in a 
continuous flow single-mode microwave reactor
40
 using a 
previously established ‘polyol process’
41–43
. This reduction 
method of ionic, inorganic precursors dissolved in liquid 
polyols (polyhydroxy alcohols) utilises microwave irradiation to 
achieve more uniform heating, nucleation control and 
increased reaction rates. Thus AgNPs could be produced from 
a silver acetate substrate within a matter of seconds
40
. The 
penetration depth of microwaves (a few centimetres) renders 
the scale-up of batch production impractical yet is still large 
enough to rationally design a continuous-flow synthesis 
system with high yields. 
Figure 2 Experimental set up for the production of HGNPs produced from galvanic 
replacement of sacrificial Co templates, including stages PEG functionalisation and 
sterilisation on a singular platform, scaled up for high throughput. Reprinted with 
permission from  L. Gomez, V. Sebastian, S. Irusta, A. Ibarra, M. Arruebo and J. 
Santamaria, Lab Chip, 2014, 14, 325–332. Copyright (2014) Lab Chip. 
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  Similarly, hollow gold nanoparticles (HGNPs) particularly 
require strict dimensional control within large-scale 
production, unachievable by batch processes. This is because 
the ratio of shell diameter to thickness determines the peak 
position of its surface plasmon resonance (SPR), while 
uniformity controls SPR bandwidth. High quality HGNPs were 
produced from galvanic replacement of sacrificial Co 
templates, including stages for poly-ethylene glycol (PEG) 
functionalisation and sterilisation on a singular platform with 
rational use of reactants and no need for time consuming 
purification steps by the scheme depicted in Fig. 2. In this 
regard, continuous microfluidic systems must be considered as 
a key tool in the future of large-scale and green routes for NP 
synthesis
44
. 
  Aside from the capability for scaling-up, modern synthetic 
chemistry is required to be sustainable. Another ‘green’ 
synthetic route for AuNP production lies in biosynthesis, with 
methods not requiring the high-energy input of irradiation 
based methods. An approach presented by Sathiskumar et al. 
utilises extract from commercially available Illicium verum (star 
anise, SA) in an effective one-step and economical synthesis of 
biocompatible AuNPs at room temperature. Although boiling is 
required for extraction, biologically synthesised AuNPs 
exhibited 20x and 5x fold toxicity reduction in A549 cells 
compared to those produced synthetically via sodium 
borohydrate and citrate reduction mechanisms respectively. 
This was attributed to the protective capping of NPs by 
polyphenols present in SA extract, with bio-AuNP exposed cells 
displaying reduced caspase levels, a key protein in the 
mechanism of apoptosis
45
. AuNPs have been biosynthesised 
using the fruit extract of Couroupita guianensis (cannonball 
fruit) as a bio-reducing agent of Au
3+
 to yield anisotropic face 
centred cubic crystalline structured particles of 26±11 nm 
diameter, with high stability and purity
46
. These NPs also 
possessed extraordinary antioxidant properties, as revealed by 
in vitro assay, and free radical scavenging capabilities making 
them ideally suited to nanomedicine. In a similar vein, AgNPs 
have also been extracellularly synthesised without surfactant 
or external energy by mixing silver solution with extracts from 
Azadiracta indica and Zingiber officiale (Neem and Ginger 
respectively)
47,48
. This synthesis produced physiologically 
stable, highly biocompatible AgNPs within 1-2 h compared to 
the 2-4 days required by microorganisms in in vivo NP 
production. Biosynthesised NPs produced by Potara et al were 
used to probe C26 murine colon carcinoma cells in vitro to 
reveal subcellular components and the localisation of the 
AgNPs by confocal Raman spectroscopy and K- means 
clustering analysis
48
. Further to the examples provided, a 
comprehensive review of green NP sources and their 
significance to cancer management and developing anti-cancer 
stem cell therapeutics through enhanced biocompatibility is 
presented by the Sreelekha and coworkers
49
. As with 
traditional synthetic methods, the major limitation of 
biosyntheses lies in their batch production format, presenting 
difficulties in upscaling production. A lack of inter-batch 
reproducibility was also reported as a result of natural 
variation in the polyphenol content of SA, despite minimal 
variation in toxicity within each batch of product
45
. Therefore, 
the classical trade-off between sustainable and large-scale 
industrial synthesis is also applicable to NP production, thus 
requiring further development. 
Nanoparticle-Cell Interactions 
The interaction between living cells and any exogenous 
material is one of great complexity. The cellular matrix is a 
vastly complicated environment which plays host to a range of 
internal structures and sensitive biochemical pathways, 
possessing variety in cargo uptake processes and transport 
vesicles. Therefore, it is with caution that NPs are introduced 
to living cells for developing models of healthy in vivo cells, as 
mechanistic understanding of how physiochemical properties 
of NPs affect NP/cellular interactions is limited. Although 
AuNPs are generally considered non-toxic to live cells 
(discussed later), evidence exists that their prolonged presence 
within the intracellular matrix does perturb its biology and 
induces stress
9,10
. SERS has been carried out using glass 
capillary probes decorated with AuNPs to detect proteins or 
metabolites both intra-
50–52
 and extracellularly
53
 to overcome 
this issue. This review however focusses on the more widely 
applied NP-based intracellular SERS approach, in which NPs 
can be applied to samples as a probe reagent for 
internalisation at the time of analysis so as to minimise the 
effects of prolonged exposure on cellular pathways and thus 
yield sizeable advantages over conventional labelling 
techniques. 
 
Cellular Internalisation Methods 
  The key to successful utilisation of NPs inside cells for SERS 
and other measurements is understanding and manipulating 
their mechanism of uptake and cellular distribution. 
Internalisation methods generally fall into three categories: 
involuntary delivery by physical methods, passive diffusion, 
and active (or voluntary) uptake.       
  The basis of physical insertion methods is the theory of 
applying a force to the cell in order to create localised 
membrane pores and increase cell permeability. 
Electroporation and microinjection achieve this with the 
application of electrical and physical force respectively
54
. 
Microinjection has been of particular interest in single cell 
studies, providing tight control of dosage and timing of 
delivery but is highly sensitive as inappropriate use (injection 
pressure, location) can easily damage cellular components. 
Single 100 nm AuNPs have been delivered to mammalian cell 
nuclei by combination of optical tweezing and opto-
injection
55
, along with using laser irradiation to also assist NP 
injection of 15-30 nm AuNPs
56
. Despite the tight control 
offered, the complexity of both procedure and 
instrumentation limits the technique which is also confined to 
larger NPs
57
. The major advantage of NP uptake by passive 
diffusion is that internalised cargos enter the cytosol directly 
and are not required to escape from vesicles involved in 
endocytosis. Colloidal semiconductor core/shell quantum dots 
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coated with the zwitterionic thiol ligand ᴅ-penicillamine 
effectively represent globular proteins in size, near-neutral 
surface charge and surface functional groups are internalised 
by HeLa cells via clathrin-mediated endocytosis
58
. However, 
these were also shown to enter erythrocytes by passive 
diffusion (given their lack of endocytotic machinery) without 
formation of holes in the lipid bilayer
59
. AuNPs of diameter 
≤200 nm have been observed to penetrate the bilayer of 
erythrocytes
60
.  
  The uptake mechanism of AgNPs in yeast cells was recently 
investigated, comparing entry by electroporation with diffusive 
approaches by TATHA2 peptide functionalised (facilitated) and 
citrate capped AgNPs for uptake by endocytosis
54
. The TATHA2 
is 1 to 20 amino acid sequence of the influenza A virus 
hemagglutinin protein (HA2) connected to a 10 amino acid cell 
permeable HIV Trans-Activator of Transcription (TAT) protein 
transduction domain (PTD). The TAT PTD binds to the cell 
surface and penetrates the membrane while the pH sensitive 
lipid membrane destabilising sequence of the HA2 domain 
facilitates endosomal escape and transduction of the fusion 
peptide. In the above work by Bhardwaj et al
54
 it was found 
that although yeast cells can tolerate high electroporation 
doses, severe damage was observed with the presence of 
AgNPs. Free diffusion of AgNPs resulted in poor uptake, 
internalisation and endosome entrapment whereas these 
parameters were rapid and large with TATHA2-AgNPs. A 
uniform intracellular distribution was also observed, which is a 
requirement for detection of ubiquitously distributive 
molecules in cell based biosensors. Conjugation of cell 
penetrating peptides (CPP) such as arginylglyclaspartic (RGD) 
or nuclear localisation signal peptides (NLS) to NPs have also 
facilitate cellular uptake
61–65
, as well as guiding probes out of 
the endolysosomal pathway as discussed under the section on 
‘Manipulating Interactions’. 
  Voluntary uptake of particles via endocytosis is by far the 
most commonly used internalisation strategy, whereby 
metallic species are taken up by the cell’s intrinsic machinery. 
This is owing to the method’s relative simplicity and minimal 
sample preparation as well as tunability by appropriate surface 
modification
66
.  
 
The Endocytotic Pathway 
  For the intake of small proteins and ions into the cell, special 
transport channels enable their translocation across the cell 
membrane
67
. For macromolecules and proteins which are too 
large to pass directly through the plasma membrane, the cell 
possesses different mechanisms for their intake from the 
environment. These intake mechanisms are generally referred 
to as endocytosis
67
, the commencement of the vesicular 
endolysosomal pathway through the cell (white arrow in Fig. 
3A).  
  In the first step of endocytosis, cargo for internalisation is 
engulfed by invagination, or pit formation, of the plasma 
membrane (black box in Fig. 3A). Pinching off from the plasma 
membrane, a small membrane-bound vesicle is formed which 
encapsulates the ingested molecule(s). Many routes of 
endocytic uptake into the cell exist. A particular intake 
pathway depends on the kind, size, shape and surface 
characteristics of the molecules (e.g. charge) as well as the 
specific cell type. Broadly, these pathways are divided into 
phagocytosis, macropinocytosis, endocytosis via non-coated 
vesicles and energy-dependent, receptor-mediated 
endocytosis
68–73
 (Fig. 3Bi-vi respectively). 
  There are a number of endocytotic mechanisms which are 
non-specific, absorptive and/or use processes that have not 
yet been identified (Fig. 3Biii). In contrast, receptor mediated-
endocytosis (RME) has been studied extensively
67
. RME is 
linked to the interaction of the receptor and the cargo to 
initiate the internalisation process via pit formation. Vesicles 
emerging from the plasma membrane usually have a size of 50 
– 200 nm depending on the involved receptor and coating 
molecules (e.g. clathrin or caveolin). The receptor is initially 
internalised with the ligand and is gradually recycled to the 
plasma membrane (Fig. 3Bvi). Thus, this process is saturable 
and used for transmembranal signal transduction
67
. Alongside 
with the disassembly of the coating molecules from the 
individual vesicles as shown in Fig. 3Bvi, these vesicles fuse to 
form early endosomes (light-green vesicles in Fig. 3).  
  Early endosomes are initially relatively small, have a mildly 
acidic pH and are known to be the main sorting station in the 
endosomal pathway. While intravesicular fluids are recycled, 
early endosomes fuse with other incoming cargos from 
different internalisation pathways (as shown in Fig. 3A-B) and 
undergo a maturation process developing into late endosomes 
(green vesicles in Fig. 3A)
71,74
. While this happens, the pH 
inside the vesicles decreases further. Late endosomes are 
bigger in size and their morphology changes during 
BA
Figure 3: (A) A schematic of a cell highlights different compartment. The endocytotic 
pathway is indicated by the white arrow in the background. After internalisation of 
the cargo into membrane-bound vesicles inside the cell (light-green, (B) for more 
details), these vesicles fuse to early endosomes and mature to late endosomes, here 
shown as green vesicles. Primary lysosomes (abbr. PL, here with light blue 
colouration) emerge from the Golgi apparatus (G) and merge with endosomes (E, 
green colouration) to form secondary lysosomes (SL, darker blue colouration). 
Passing through maturation and degradation processes, they get eventually 
exocytosed by the cell. (B) Detailed schematic showing the main mechanisms of 
endocytosis featuring phagocytosis (i), macropinocytosis (ii), non-specific absorptive 
endocytosis (iii) and receptor-mediated endocytosis (vi) involving receptor (yellow 
shape) and coating molecules (e.g. clathrin- and caveolin, blue triangle). Abbr.: 
cytoplasm (C), early and late endosomes (E), endoplasmic reticulum (ER), Golgi 
apparatus (G), mitochondria (M), nucleus (N), primary lysosome (PL), plasma 
membrane (PM), ribosome (R), secondary lysosome (SL), vacuole (V). Figure is not 
to scale. 
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maturation
71
. At the end of the endosomal pathway, late 
endosomes as well as phagosomes eventually fuse with 
primary lysosomes to form secondary lysosomes or 
phagolysosomes, containing components from both fusion 
partners
71
. Hereafter, NP cargos can localise into various 
cellular compartments dependent on characteristics such as 
size and surface coating. Transport to the nuclear membrane, 
translocation across the nuclear membrane and rejection 
from the cell by exocytosis can all occur, although penetration 
into nuclear membrane is difficult to achieve with 
administered NPs clustering at the membrane or dispersing in 
the cytoplasm
16,66,75
. The fused primary lysosomes emerge 
from the Golgi apparatus (Fig. 3A) and contain numerous 
enzymes (e.g. hydrolase) along with various macromolecules 
from other intracellular, catabolic processes and due to 
membrane turnover. Those molecules have previously been 
incorporated through autophagy
71,76
. During the lysosomal 
pathway, most of the molecular digestion and degradation 
takes place while the pH
77
 in these vesicles becomes more and 
more acidic. Subsequent dynamic changes of the molecular 
composition and the activity of enzymes inside the vesicles 
also result in modification of the encapsulated 
molecules
67,69,78
. At the end of the lysosomal pathway, 
vesicles with indigestible material become residual bodies and 
are secreted from the cell via exocytosis
24,76,79
. Different 
maturation and fusion steps within this whole pathway are 
colour-indicated in Fig. 3A.  
  The advantage of the uptake of plasmonic NPs by endocytosis 
is its simplicity, both in execution and sample preparation. The 
typical procedure following particle synthesis consists of an 
incubation period of cells with NPs suspended in culture 
medium before washing and SERS investigation. Tunability is 
afforded by altering NP properties such as size, shape and 
surface coating, which can be manipulated to localise SERS 
nanoprobes to desired cellular locations or access or escape 
specific pathways and transport vesicles. 
 
Manipulating Interactions 
  It is of great importance to understand and quantify the 
intracellular uptake of AuNPs. Extensive studies have shown 
that many factors, including size, shape, surface coating, 
concentration of NPs, aggregation state of NPs, the type of 
cell, the type of culture media and the exposure conditions 
play important roles in their biological interactions
80
. With 
innovations in nanotechnology, a library of fit-for-purpose 
AuNPs with different physicochemical properties has  been 
established
5,81–88
. 
  A straightforward parameter to manipulate during synthesis 
is NP size (diameter). With the intention to carry out 
intracellular SERS experimentation, several factors contribute 
to identifying the optimal NP diameter. AuNPs larger than 15 
nm have a sufficiently large scattering cross-section and 
exhibition of plasmonic activity to provide the required optical 
contrast and electric field enhancement, which must be 
considered when utilizing optical based analytical tools for the 
localization of AuNPs inside cells
89
. Additionally, a NP must 
also be efficiently internalised by the cell. Studies have shown 
that the optimal diameter for endocytotic uptake of AuNPs is 
around 50 nm; although this depends on other factors 
previously mentioned. Size dependence of uptake is associated 
with ‘wrapping time’, the numerically determined time 
required for elevation of membrane receptor density to 
achieve complete invagination of the NP, with all of its surface 
area in contact with membrane. This is affected by factors 
including ratio of adhesion, membrane stretching and 
membrane bending. Optimal values of wrapping time have 
been calculated as 2-58 s for three dimensional NPs of 
diameters 54-60 nm
77
. Practically, HeLa cells in Dulbecco 
medium exhibited greater uptake of 50 nm AuNPs compared 
to sizes of 14, 30, 74 and 100 nm, showing agreement with 
theoretical simulations
79,80
. It was shown that 55 nm AuNPs 
had the fastest wrapping time, with RME receptor binding of a 
NP producing enough free energy to drive it into the cell. This 
free energy is reduced in NPs of diameter <50 nm, which are 
therefore required to cluster together in order to achieve 
internalisation. 14 nm AuNPs are thus required to cluster with 
at least 5 other particles for internalisation. Conversely, 
wrapping times of large NPs are increased because more RME 
receptors are required to bind their larger surface area and 
generate sufficient free energy for internalisation. 
Consequently, the number of AuNPs entering the cell in 
transport vesicles is reduced; with uptake rate limited by the 
speed of diffusion of extra receptors to the site of 
invagination
77,79
. Hence, most intracellular SERS studies 
conducted utilise spherical AuNPs in the diameter range 40-60 
nm. 
  A prominent mechanism for aiding cellular uptake via 
endocytotic pathways is to facilitate the diffusion by 
Figure 4: Illustration of the protein corona around a spherical gold nanoparticle in a 
protein-rich environment. Proteins, here shown as blue entangled chains, adhere to 
the particle’s surface forming a ‘hard’ (i) and ‘soft’ (ii) layer. While the inner ‘hard’ 
layer consists of proteins strongly adsorbed to the particles surface, the outer ‘soft’ 
layer is formed by weak protein-protein interactions. 
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employing surface modification. Following production by 
previously discussed synthetic methods, there is a common 
requirement for stabilisation in order to prevent further 
growth or aggregation. Charged ligands such as citrate are 
often utilised for this purpose as coulombic repulsion serves to 
keep produced NPs separate. However, the negative charge 
possessed by citrate and other ligands is unfavourable for 
interaction with the similarly negatively charged cell 
membrane upon nanoparticle feeding, a process which rather 
favours small uncharged cargos. In solution-based conditions, 
macromolecules such as serum proteins adhere to the noble 
metal surface by physical or chemical adsorption to produce 
the double layer structure displayed in Fig. 4, known as the 
‘protein corona’. These two layers about the colloid consist of 
an innermost ‘hard’ layer bound directly to the Au surface by 
strong attractive force and secondary outer layer, comprised 
of proteins weakly adsorbed to the nanoparticle via 
intermolecular forces such as protein-protein interaction 
which shields the inner layer from the particle environment
90
. 
Despite this, the make-up of the protein corona is subject to 
dynamic changes in composition and thickness (usually 
measured between 3-15 nm in thickness) with adsorbed 
proteins affecting the hydrodynamic diameter of an NP. Initial 
formation of the corona occurs rapidly upon contact and in the 
case of culture medium, a stable and biocompatible structure 
is formed
90
. This process is of huge synthetic advantage for 
functionalisation of nanoparticles to achieve facilitated uptake 
and cellular compartment targeting as even inner layer 
proteins can be substituted at the surface following a few 
hours’ incubation with desired ligands, requiring minimal 
sonication or heat input. This hard corona layer gives the 
nanoparticle its biochemical identity as experienced by the cell 
upon contact and remains relatively unaffected by biophysical 
events such as internalisation- therefore selection of ligand is 
crucial in achieving the desired uptake and localisation of a 
SERS nanoprobe. However, environmental changes such as 
enzymatic presence or the pH are only experienced by the 
outer corona layers, allowing for the use of organic molecules 
as SERS labels or attachment of fluorescent tags in (or as) the 
inner layer. 
  As previously mentioned, surface modification of AgNPs by 
TATHA2 has achieved enhanced uptake by endocytosis in yeast 
cells
54
. Cellular entry and escaping endolysosomal vesicles into 
the cell through the plasma membrane is associated with the 
ability to penetrate or pass through the lipid bilayer. 
Permeability of the lipid bilayers is known to be achieved by 
the interaction of cationic molecules with the negatively 
charged plasma membrane which is thereby disrupted and 
forms nanopores. The choice of molecules spans amine-
containing polymers
6-8
, polypeptides
9
 and cationic liposomes
10-
12
. PEGylation of NPs is a very common surface modification 
for aiding cellular internalisation, providing a ‘masking’ effect 
for the NPs to cells of the immune system
91
. They are also 
more tolerant to salt aggregation and either citrate or CTAB 
coated NPs, with smaller cargos being less imposing to cell 
biology. An additional benefit is that PEG coating hydrophilises 
the NP surface to serve as a ligand for the attachment of drugs 
or genes for targeted delivery
92–94
.  
Once internalised, a wide range of biochemical delivery 
strategies are known for evading endolysosomal vesicles. 
Typically, they are based on the conjugation of the particle 
surface with various types of molecules such as cationic 
molecules
1
, protein transduction domains, CPPs
2-4
 and 
ligands
5
. Rhim and co-workers have demonstrated the 
cytoplasmic localisation of AuNPs conjugated to cationic 
liposome alongside plasmid DNA resulting in an improved 
efficiency of cellular transfection
95
. This is thought to be 
achieved by charge neutralisation by liposomes of the plasmid-
AuNP complex which results in a more favourable interaction 
with the plasma membrane
12
. 
  Furthermore, CPPs have widely been applied to target 
specific intracellular organelles. Many peptide sequences have 
been derived from natural systems used by viruses such as the 
TAT peptide derived from the HIV-1 virus which, conjugated to 
AuNPs, is known to allow cytoplasmic localisation
3, 13-15
. Even 
though the exact mechanism of its interaction with biological 
membranes is not yet known, TAT is thought to mediate 
cellular import via multiple routes including direct membrane 
passage
14, 16
 and intake through endocytosis
15, 17
.  
  Ligand molecules facilitate the directed interaction of the 
cargo with specific receptors by binding to them. This can be 
used for the delivery of AuNPs into cells as for instance shown 
by Tkachenko and co-workers who demonstrated that NPs 
modified with adenoviral RME peptides gain entry into cells via 
RME
75
. Furthermore, ligands have particularly been used to 
target selected cellular components such as the nucleus with 
attachment of nuclear localisation signal (NLS) peptides
63,65
.  
 
Toxicity 
  A vital consideration to the intracellular SERS experiment is 
the effect of the administered NP on its host. That is, any 
change or decline in key cellular processes induced by particle-
cell interactions decrease the validity of the investigation 
conducted, as the in vitro cell model becomes less 
representative of the natural state.  In general, cytotoxicity of 
NPs is attributed to the size of both single particles and 
clusters thereof, surface modifications, NP concentration and 
composition of the protein corona in addition to the cell 
type
24,96–98
. Their size determines the crossing of lipid 
membranes by NPs into various subcellular structures 
possessing size exclusive pores. Confinement of NPs in cellular 
vesicles such as endosomes may however still present toxicity, 
when local concentration of noble metal far exceeds its LD50 
(the concentration at which a molecule dose is fatally toxic to 
50% of a population). Smaller particles have high surface to 
volume ratio and therefore can have increased level of 
interactions with the environment. Indeed single particles of 
size less than 2 nm in diameter have been shown by several 
studies to have damaging effects on cells
96,99–101
.  
  In addition to size based effects, homeostatic mechanisms are 
also disrupted by the presence of ‘foreign’ noble metal within 
the cell. Oxidative stress results from the production of 
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reactive oxidative species (ROS) upon cellular recognition of 
foreign material and is usually compensated for by 
homeostatic defence mechanisms. However, at high metal 
concentrations these mechanisms are unable to maintain 
normal cell function, therefore cause toxicity and cell death
100
.  
  Surface modifications also impede upon cell viability. 
Oxidative stress, evidenced by compromise of mitochondrial 
potential, integrity and substrate reduction along with 
presence of ROS, was induced in HeLa cells by 
Triphenylphosphine monosulfonate capped 1.4 nm AuNPs to 
show increased cytotoxicity relative to 15 nm AuNPs of similar 
chemistry
100
. However, pretreatment of the 1.4 nm NPs with 
reducing agents/antioxidants N-acetylcysteine, glutathione, 
and TPPMS reduced the observed toxicity. AuNPs of similar 
size but capped with glutathione also induced no oxidative 
stress. Besides the size dependence, ligand chemistry was also 
therefore defined as a critical parameter for biocompatibility 
and toxicity of AuNPs
100
. 
  The material of the nanoparticle is bound to have an effect. 
For instance, AgNPs are frequently reported as toxic
102–106
 by 
the induction of oxidative stress to host cells, exhibiting 
protein misfolding, mitochondrial dysfunction and impaired 
DNA repair leading to cell death
103
. This apparent toxicity can 
however be advantageous for applications in cancer therapy, 
with AgNPs shown to be toxic towards tumour cell lines HeLa 
and U937
105
. In contrast, AuNPs are usually considered to be 
non-cytotoxic and inert with limited reports of adverse 
effects
104,107–109
. Direct comparison of the two materials’ 
toxicity is complicated by the large number of factors 
described in this section, including the differing surface 
coatings required for stability. 
 The effects of shape, surface chemistry and NP concentration 
were reported by Hutter
110
, who studied the viability of 
microglia when incubated with spherical AuNPs, nanorods and 
nanourchins coated with either PEG or CTAB. No toxicity was 
associated with any variant at low culture medium NP 
concentrations (<9x10
9
 NPs mL
-1
), however at 9x10
9
 NPs mL
-1
 
cellular activity was reduced by 94% following exposure to 
CTAB coated nanospheres with no relative toxicity exhibited in 
the other CTAB particle shapes (slight toxicity in CTAB 
nanorods with 13% activity reduction at 10
11
 NPs mL
-1
). The 
modest reduction in cell viability in Au NRs compared to Au 
nanospheres was likely due to the increased uptake rate of 
nanospheres. The finding that CTAB coated NPs bore a greater 
toxicity than those coated with PEG is consistent with 
numerous other studies
110,25
. CTAB is used in synthesis as a 
shape-directing agent and stabilising ligand due to its positive 
charge, which forms strong interactions with the negatively 
charged plasma membrane. This disruption of membrane 
structure is responsible for  CTAB’s associated toxicity to cells 
at concentrations over ~10 nM
97,101,110
. Reduction of this 
toxicity can however be achieved by surface modification with 
other capping agents such as PEG
111
, PAA
112
, PAH
112
 and 
polystyrene sulfonate
113
.  
  In spite of numerous toxicity studies, there remains a 
fundamental requirement for standardisation of investigative 
procedure before an acceptable consensus on AuNP toxicity 
can be reached
114
. Various shortcomings in toxicity assays for 
NP applications have been identified, including lack of 
complete characterisation of NPs utilised in experiments, 
inconsistent reporting of NP concentration (mass per volume 
gives no indication of NP size, which directly impacts toxicity), 
and a lack of standardisation of toxicology method parameters 
such as dose range and incubation media
115
, all of which make 
comparisons between nanoparticles complicated. For instance, 
the aforementioned toxicity of CTAB has also been attributed 
to the free molecule’s presence in AuNP solution, which raises 
the need for tight ‘supernatant control’ steps to be taken for 
valid NP toxicity evaluation
97,112
. Additionally, NPs themselves 
may affect performance of routine toxicity assays, requiring 
validation in the presence of the specific type of NP employed 
as variation in structure or size may alter the performance 
differently
115
. Current ambiguities arise from two predominant 
factors, the first being the complex governance of the 
phenomenon by a large number of both chemical and physical 
properties of the NP along with cell types and the degree of NP 
internalisation. The second being a lack of standardisation in 
experimental design, execution of procedure and data 
treatment
114
.  
  To illustrate the latter point, Fratoddi et al. gathered existing 
data from published studies conducting MTT assay of HeLa 
cells exposed to differently functionalised AuNPs, for analysis 
by metric numerical particle concentration as opposed to mass 
concentration or particle size
114
. This produced a simplified 
view of how parameters such as NP size, concentration and 
surface coating impact individual cell viability and concluded 
that size dependence is much less important than the number 
of particles present per unit volume. Differently functionalised 
AuNPs behaved similarly, with the surface coating of the NPs 
defining the range of particle concentrations at which toxic 
effects commence. 
 Thus overall, the requirement for standardisation of 
nanoparticle internalisation protocols and data treatment 
remains eminent for the progression of SERS experimentation 
on single cells in vitro and beyond, however promising steps 
are being taken to achieve this.  
Intracellular SERS 
  The first application of SERS within cells was carried out in 
1991 when Nabiev et al. detected the presence of antitumor 
drugs doxorubicin (DOX) and 4’0-tetrahydropyranyl-
adriamycin (THP-ADM) in the nucleus and cytoplasm of living 
cancer cells using citrate reduced AgNPs
116
. Since its first 
intracellular utilisation, SERS has been successfully applied for 
detection of a vast array of biological markers and metabolites, 
in turn for sensing and tracking environmental changes 
through cellular pathways and processes. These include 
monitoring of cellular functions
117,118
, dynamics
119,120
, enzyme 
kinetics
121,122
, stress response
123
, apoptosis
124
 and cell death
125
 
along with probing specific compartments such as the 
mitochondria
126
 and tracking of drugs released into the 
cytoplasm by NP carriers
61,127,128
.  
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  The cell-based SERS experiment generally takes one of the 
following two methodologies: the SERS-Reporter (SERS-label) 
approach or the Reporter-free (label-free) SERS approach. 
While the SERS-Reporter approach has been more dominant 
over the last decade the merits of the label-free approach 
have begun to emerge with concomitant advancements in 
computational approaches. A review of research advances and 
developments in both methodologies is presented below. For 
general and exhaustive reviews of SERS applications in the 
biological context, also covering the SERS-reporter approach 
inside cells, the reader is referred to a few excellent recent 
publications
5,70,129,130
. 
 
Advances in SERS Reporter Research 
 The first and more comprehensively studied intracellular SERS 
technique is the SERS reporter approach, whereby NPs are 
functionalised with covalently bound, strongly Raman active 
organic molecules. Such molecules serve specific sensing 
purposes by binding to a target molecule. The generated SERS 
spectrum then reveals the defined signature of the label to 
facilitate indirect and highly sensitive detection of the target 
molecule for Raman sensing applications. A specific example of 
this concept is the use of 4-mercaptobenzoic acid (4-MBA) 
functionalised NPs as pH sensors, which are sensitive to 
changes between pH 6-8 within their in cellulo 
environment
131,132
. This is owed to spectral differences 
between the molecule’s protonated and deprotonated forms 
(1430 cm
-1
 COO
-
 stretch, specific to deprotonated form in 
basic conditions)
131
. More recently, this 4-MBA pH sensing 
was multiplexed with simultaneous measurement of redox 
potential in live EAhy926 cells. The redox sensitive band at 
1666 cm
-1 
(C=P stretch) reports on the oxidation state of SERS 
reporter molecule N-[2-({2-[(9,10-dioxo-
9,10dihydroanthracen2yl) formamido]ethyl}disulfanyl)ethyl]-
9,10-dioxo-9,10-dihydroanthracene-2-carboxamide (AQ), 
which was ratiometrically plotted against  its redox insensitive 
1606 cm
-1
 (C=C stretch) vibrational mode. Cluster analysis 
then permitted quantitative analysis of redox potential 
dysregulation, a common indicator for the progressive 
pathology in neurodegeneration, cardiovascular diseases and 
cancer
132
. 
  The density of SERS labels on the surface of the plasmonic 
NP can be adjusted to experimental needs. For instance, the 
co-adsorption of other, undesired molecules as well as spectral 
interference can be avoided by complete coverage of the NP’s 
surface with the label. Additionally, a (further) physical and 
chemical protection of the probes can be achieved by 
encapsulation with a silica layer as conceptually introduced by 
Mulvaney and co-workers
133
 following subsequent 
advancement in synthesis to achieve ultrathin silica 
shells
34,83,134
. Hollow AuNPs can also be protected by PEG 
capping, offering stabilisation and red shifting their SPR from 
700 nm for detection by 785 and 1064 nm irradiation
135
. Many 
SERS labels (reporter molecules) have been developed since 
the technique was established including enzymes, dyes, 
peptides and DNA which allow for multiplexed detection of 
numerous molecules using only a single laser wavelength. 
Multiplexing of SERS reporter functionalised nanoprobes 
allows for a much broader range of molecules to be 
simultaneously studied when compared with fluorescence 
microscopy, due to spectral resolutions of <2 nm which could 
enable access to between 10-100 unique optical signatures as 
provided by varying reporter molecules
65
. 
   
Figure 5: (A) SERS response and sensing mechanism of palladacycle carbonylation on 
AuNP/PC nanosensors for CO. (B) SERS detection of CO in living cells using AuNP/PC 
nanosensors. Reprinted with permission from Y. Cao, D.-W. Li, L.-J. Zhao, X.-Y. Liu, X.-M. 
Cao and Y.-T. Long, Anal. Chem., 2015, 87, 9696–9701. Copyright (2015) Anal. Chem 
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  SERS reporter experiments benefit from the specificity of 
attaching a specific organic molecule to the NP and mapping 
its known SERS signature, suitable for various intracellular 
sensing applications. Stevenson et al. presented the first use of 
SERS reporter methodology to monitor the intracellular 
activity of specific enzymes, a tool which could possibly be 
implemented to detect dysfunction underlying many 
diseases
136
. A recent example of this concept is the detection 
of carbon monoxide in normal human liver and HeLa cells
137
. 
This sensing is based upon the sensitivity of SERS signal from 
40 nm AuNP-bound palladacycle reporter ligands to 
carbonylation, induced by the presence of carbon monoxide, 
whereby the palladium constituent is removed from the ligand 
to form a carboxylic acid group as presented in Fig. 5
137
. Inside 
cells, the presence of carbon monoxide releasing molecules 
(CORMs) was thus evidenced by the appearance of spectral 
bands at 1032 cm
-1
 (R-NH2 rocking), 1118 cm
-1
 (νCX stretch) 
and 1242 cm
-1
 (νCO stretch). The lowest detection limit of 
CORMs was found to be  0.5 µM in HeLa cells, attributed to the 
1032 cm
-1 
vibrational peak
137
. This finding offers potential to 
utilise palladacycle based SERS reporters as an analytical 
technique to develop a much required knowledge of 
pathophysiological events involved with carbon monoxide. 
These examples demonstrate the typical sensing-styled 
application of intracellular reporter SERS methodology as well 
as its high sensitivity. 
  As a well understood technique with high specificity, SERS 
reporter methodologies have been developed into therapeutic 
applications such as the detection of inflammation as 
demonstrated in vivo in murine models with twice the 
sensitivity of two photon fluorescence techniques
138
. However, 
SERS is of particular interest to oncology. Antibodies selective 
to proteins overexpressed in cancer cells have been used to 
target SERS reporter probes for diagnostic applications
139–142
. 
Dual SERS-fluorescence diagnostics have been carried out 
using a fluorescently labelled aptamer for targeting protein 
tyrosine kinase, conjugated to Au-Ag nanorods also bound 
with Raman reporter molecule 4-aminothiophenol. SERS and 
fluorescent signals could be excited independently using 
different wavelengths of light for combined cancer cell 
recognition
141
. Monoclonal antibodies have also been used to 
selectively target 40 nm AuNPs with squaraine dye reporter 
molecules to epidermal growth factor and p16/Ki-67 receptors 
to achieve selectivity to and recognition of cancer cells’ surface 
and nucleus
142
. Therefore, SERS can be presented as a 
potential means of fast and accurate cancer diagnosis 
compared to time consuming immunocytochemistry 
methods
141,142
. 
  Efforts have been made to combine the detection of cancer 
biomarkers with microfluidic technologies
143–147
, however this 
is mostly conducted at the cellular level. For instance, 
circulating tumour cells were detected in blood plasma by 
labelling of Ag-Au nanorods with a mixture of four SERS dyes, 
along with an ‘antibody rainbow cocktail’ of four breast cancer 
antibodies and a specific leukocyte CD-45 marker. This 
resulted in highly specific detection of a single cancer cell in a 
population of seven million blood cells when applied with 
multicolour and photothermal imaging. The presence of the 
SERS reporter dyes could be effectively imaged on the 
membrane of such tumour cells
139
. Similarly, multicore SERS 
reporter labels functionalised with epithelial cell adhesion 
molecule antibodies have been shown to bind the membrane 
of living MCF-7 tumour cells without cellular uptake following 
just 25 ms exposure time. Potential for enumeration and 
sorting of circulating tumour cells is therefore very promising 
with microfluidic chips
147
.  
  Of great relevance to subcellular events is utilising SERS 
reporter NPs to achieve traceable intracellular drug delivery in 
therapeutics. A AgNP-loaded, graphene oxide based 
nanoplatform has been employed by Huang et al. to not only 
achieve pH sensitive delivery of antitumour drug DOX into live 
cells, but also to monitor its release by SERS
148
. Similar pH 
sensitive DOX release and SERS tracking has also been 
achieved by loading into multi-walled carbon nanotubes 
decorated with 4-MBA labelled Au and Ag core-shell NPs, 
verifying the drugs release inside lysosomes by imaging of its 
fluorescent signal with mapping SERS-determined cellular 
pH
149
. Song et al performed successful delivery and monitoring 
of DOX in live SKBR-3 cells using hollow, amphiphilic SERS-
reporter vehicles
62
. These particles consisted of 14 nm 
diameter AuNPs, coated with hydrophilic PEG, pH-sensitive 
hydrophobic PMMAVP grafts and the Raman reporter 
molecule BGLA (2-(4-(bis(4-
(diethylamino)phenyl)(hydroxy)methyl)phenoxy)ethyl 5-(1,2-
dithiolan-3-yl)pentanoate). The functionalised AuNPs were 
then self-assembled into hollow plasmonic vesicles tagged 
Figure 6 (A) Schematic illustration of the amphiphilic gold nanoparticle coated with 
Raman reporter BGLA and mixed polymer brushes of hydrophilic PEG and pH-sensitive 
hydrophobic PMMAVP grafts and the drug-loaded plasmonic vesicle tagged with HER2 
antibody for cancer cell targeting. (B) The cellular binding, uptake, and intraorganelle 
disruption of the SERS-encoded pH-sensitive plasmonic vesicles. (C) Representative 
SERS spectra of SKBR-3 cells treated with HER2-targeted vesicles (black line) and 
untargeted vesicle (purple line), MCF-7 cells treated with targeted vesicles (red line), 
and SKBR-3 control cells (blue line). (D) Representative SERS spectra of SKBR-3 cells 
labeled with targeted vesicles after 30 min incubation (black line) and the 
postincubation spectra of the cells at 60 min (red line) and 90 min (blue line). 
Reprinted with permission from J. Song, J. Zhou and H. Duan, J. Am. Chem. Soc., 2012, 
134, 13458–13469. Copyright 2012 J. Am. Chem. Soc. 
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with HER2 antibodies for cancer cell targeting and loaded with 
DOX as shown in Fig. 6A-B. Upon internalisation of the NP, its 
degradation is promoted by the pH decrease observed 
alongside the maturation of endosomes into lysosomes. Not 
only does degradation release the drug cargo into the cell, but 
dissociation of the assembled AuNP layer diminishes the 
previously high SERS reporter signal intensity as the dye is no 
longer held in SERS hotspots. However, as it is still bound to a 
single AuNP, signal remains sufficient to probe the chemical 
environment of the vesicle. While the vesicle-labelled SKBR-3 
cells displayed the strong Raman fingerprint of the BGLA 
probe, significantly weaker signals were detected from cells 
exposed to non-targeted vesicles and MCF-7 cells incubated 
with targeted vesicles (Fig. 6C-D). Those labelled with pH-
sensitive vesicles also exhibited gradually reduced SERS 
intensity in the same timeline, as confirmed by the results of 
plasmonic imaging. Rather than merely detect the reporter 
compound employed, this approach monitors intracellular 
drug release based on the loss of hotspot-generated SERS 
reporter intensity to infer successful drug cargo delivery
62
. 
Uncontrolled AuNP aggregation often causes inhomogeneity in 
SERS measurements (discussed in the next section on label-
free SERS), yet has been manipulated in this study to yield a 
novel analysis technique. Although NP-based long term drug 
delivery has been employed for a significant length of time, 
the prospect of monitoring the release of the drug 
intracellularly using reporter SERS represents an exciting 
development across a range of therapies with suitable 
antibodies available. In addition to drug release and 
monitoring, AuNPs have been coated with bifunctional 
conducting polymer materials, acting as both Raman reporter 
molecule and a stable surface coating to offer purpose in 
photothermal therapy. These NPs are capable of highly 
efficient near-infrared photothermal transduction for cancer 
therapy whilst possessing good stability and biocompatibility 
both in vitro and in vivo in mouse models
150
. 
  Reporter SERS methodology can also be used to interrogate 
the intracellular distribution of various molecules by 
multiplexing the Raman signal of specific reporter molecules to 
produce SERS map images of single cells. The potential for this 
was demonstrated by Gregas et al., who targeted 4-MBA-AgNP 
probes to the cell nucleus with HIV-1 protein derived TAT 
sequence modification of NPs to  characterise their location 
and produce two dimensional SERS images of PC-3 human 
prostate cells
151
. However, uncontrolled aggregation of 
spherical NPs not only causes locally heterogeneous 
enhancement of Raman signal by variable SERS hotspot 
generation, but also may prevent their internalisation or 
disrupt cell function due to the size of agglomerates. As a 
result, nanostars may be used for intracellular imaging and 
sensing. Those bound with nile blue A Raman dye and capped 
with bovine serum albumin have been utilised to map 
adenocarcinoma A549 and alveolar type II cells to identify 
constituents such as proteins, nucleic acids, lipids and 
carbohydrates as well as verifying that the SERS nanoprobes’ 
primary method of cellular internalisation was via 
endocytosis
152
. Nanostars of 60-70 nm diameter, labelled with 
toluidine blue (TB) and encapsulated in a 30 nm coating of 
silica have also been employed for probing of the intracellular 
matrix
153
. The performance of these particles was compared to 
spherical AuNPs with the same TB reporter and coating. 
Nanostars were shown by TEM to enter HeLa cells without any 
tendency to aggregate, albeit at a 3-fold reduction in 
internalisation. Upon irradiation with an 830 nm laser, SERS 
signal intensity from the nanostars was mapped across single 
cells at intensities greatly increased than that generated by 
spherical NPs, which barely exhibited a response. However, it 
must be noted when excited at 633 nm, a well-defined SERS 
signal could also be registered from the spherical 
nanoparticles, demonstrating the presence of the label within 
the silica shell
153
. Therefore the intensity differences could be 
due to the excitation wavelength and plasmon resonance 
dependence of enhancements.  
  Three dimensional SERS elucidation of Chinese hamster ovary 
cell nuclei was achieved by McAughtrie et al using nanotags 
functionalised with Raman reporters 4-mercaptopyridine, 5’5-
dithiobis(2-nitrobenzoic acid) and 4-nitrobenzenethiol 
combined with multivariate analysis techniques
154
. With data 
trends explained in all three dimensions simultaneously, 
multiple component detection was possible along with 
location of internalised nanotags was determined without the 
need for destructive TEM imaging. Such multi-marker 
approaches offer importance in delivering full characterisation 
of disease states or multiple cell organelle targeting while 
three dimensional analysis increases validity in modelling 
complex cellular structures
154
.  
  The probing of the intracellular chemical environment is very 
much a key application for SERS research given its high 
resolution and non-destructive nature. The ability to 
sensitively detect, map, monitor and quantify the localisation 
of both endogenous and extraneous molecules at the sub-
cellular level would unlock a world of new information 
regarding the molecular changes undertaken by live cells 
during a range of cellular processes. The SERS reporter 
methods presented here offer promising steps towards 
visualisation and quantification of targeted molecules across 
individual cells. However, the effects of vast amounts and 
variety of biomolecules surrounding the nanoprobes go 
unaccounted for, limiting the amount of detailed information 
available as molecular events unfold. Despite the ability to 
multiplex data with numerous reporter molecules, this is a 
limitation of the technique when fully characterising cellular 
pathways. The approach may also lack spectral resolution in 
some applications where characteristic reporter bands (such as 
the phenyl ring modes of 4-MBA) only exhibit small 
wavenumber shifts (few cm
-1
) as a function of bound 
substituents
155–158
.  
 
Advances in Reporter-free SERS 
  In contrast, in the reporter-free SERS approach the 
nanoparticles probe their direct vicinity and thus can 
potentially sense the large complexity of the chemical 
environment around them. In reality the affinity of molecules 
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to the surface chemistry (charge) will determine the 
environment in the direct vicinity of plasmonic particles (e.g. 
AuNPs). Molecules near or adsorbed onto an NP or into a NP’s 
protein corona determine the measured SERS spectrum and 
allow for (bio)chemical sensing and characterisation, to track 
cellular processes such as cellular differentiation by DNA/RNA 
ratios, for instance
63
.  As mentioned earlier, single NPs can 
aggregate, giving rise to regions of intense enhancements 
called hotspots between the particles. This electromagnetic 
field enhancement between close-proximity SERS probes 
causes molecules located in those hotspots to provide a larger 
contribution to the measured SERS spectrum, albeit non-
uniformly, as the aggregation and hence the generation of 
hotspots inside cells is largely uncontrolled. While this makes 
quantitative SERS measurements difficult, it allows for the 
qualitative but highly sensitive detection of the molecular 
environment inside cells
159
. 
  Despite the simple NP preparation involved in reporter-free 
SERS, selectively identifying molecular changes resulting from 
cellular processes in large and multidimensional data sets 
(arising from the large variety of biochemical molecules 
detected) can be particularly challenging especially in the more 
complex, eukaryotic (including mammalian) cells. Although 
examples of specific detection of molelcules, metabolites such 
as FAD and FMN have been identified, using SERS have been 
obtained with bacterial cells
160
 with continued development of 
reporter-free intracellular SERS applications with eukaryotic 
cells are likely to emerge. Moreover, the lack of simple tools 
for extracting this information has so far resulted in limited 
characterization of fundamental cellular processes, especially, 
by reporter-free SERS approaches. However, when applied 
effectively, this allows access to the vast wealth of information 
available from the raw SERS data acquired from biological 
samples such as cells
64
.  
  Owing to the fact that this approach samples numerous 
constituents of the chemical environment around a NP, 
reporter-free SERS studies have been guided towards tracking 
and characterisation applications. In a similar technique 
outlined with SERS reporter methodology
62,148
, the release and 
delivery of anticancer drug DOX was specifically tracked within 
live human oral squamous carcinoma (HSC-3) cells
61
. AuNPs of 
28 ±3nm diameter were functionalised with NLS and RGD 
peptides following (PEG)ylation, with the DOX bound to the Au 
surface by Ph-sensitive hydrazine linkage. Upon pH-dependent 
release of the drug within lysosomes, the intensity of its SERS 
band at 460 cm
-1
 was diminished with release over a 12 h 
period, with its inherent fluorescent signal no longer quenched 
by a close-proximity AuNP used to verify DOX localisation in 
lysosomes and resulting release into cytoplasm
61
. 
 The Kneipp group carried out an early probing of cellular 
compartments by reporter-free SERS in living macrophages 
and endothelial cells. Differences in the SERS spectra obtained 
in different cell lines and over time, as well as the direct 
identification of physiologically relevant molecules, 
demonstrated that reporter-free SERS approaches are feasible 
for the characterisation of changing cellular environments and 
useful for intracellular applications. Additionally, the tendency 
of internalised AuNPs to uncontrollably aggregate results from 
the changing chemical environment experienced by the 
probes, with dimer and trimer formation (revealed by 
Transmission Electron Microscopy, TEM) leading to increased 
enhancement of the Raman signal compared to individual 
particles
16
. Thus, controlling or even preventing this 
aggregation of NPs inside the cell in order to eliminate the 
incurred heterogeneity of acquired spectra from hotspots 
remains one of the key challenges to reporter-free SERS 
experiments inside cells. Novel structures, which show high 
plasmonic enhancements at the single nanoparticle level 
compared to single spherical nanoparticles, have been 
employed to overcome this hurdle, as are discussed later in 
this section. 
 Reporter-free SERS for mapping the intracellular environment 
has nevertheless been used in many applications. In a study 
conducted by Zhang et al. a microfluidic chip was used for 
delivery and immobilisation of single cells
161
. They used 
ordered continuous flow to expose Chinese hamster ovary 
(CHO) K1 cells to intracellular flux agonist ionomycin. Following 
mapping to reveal the location of the cell nucleus, cytoplasm 
and membrane, the approach was found capable of 
monitoring the chemical changes occurring within the cell 
during ionomycin-evoked Ca
2+
 flux response. This was 
achieved by observing the time profile of changing amide I 
(1643 cm
-1
) concentration, showing a similar trend to that of 
Ca
2+
 flux which is commonly used in biomedical research to 
stimulate the intracellular production of proteins such as 
interferons
162
. This demonstrates the potential to utilise SERS 
for in situ monitoring of molecules to characterise protein 
expression dynamics at subcellular levels. The continuous flow 
methodology developed also permits more time effective 
Figure 7: Schematic of experimental design. (A) Full experimental procedure 
involves AuNPs (red spheres) being added to the cell culture environment after (A.i) 
cells have sufficiently attached to the culture dish. (A.ii) Following uptake of the 
particles into the cell via endocytosis during the incubation pulse, extracellular 
particles were washed out. (A.iii) Fresh culture medium without AuNPs was added 
and the cells were left until incorporated particles were processed into lysosomes 
(depletion phase). (B.i) During the incubation phase, cells constantly internalize 
AuNPs, which accumulate inside endosomes (green vesicles) and lysosomes (blue 
vesicles), Their acquired SERS map data serves as the sample group for analysis. 
(B.ii) Following the wash-out, vesicular AuNPs are processed along the 
endolysosomal pathway and are eventually found exclusively in lysosomes. SERS 
maps of cells with only lysosomal AuNPs serve as the reference group for the data 
analysis. Reprinted with permission from A. Huefner, W.-L. Kuan, K. H. Müller, J. N. 
Skepper, R. A. Barker and S. Mahajan, ACS Nano, 2015. Copyright 2015 ACS Nano. 
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experimentation when a series of SERS measurements are 
required, relative to batch preparation and analysis
161
. 
  Reporter-free SERS has also demonstrated the capability to 
differentiate between closely related cell phenotypes in 
progenitor and differentiated cell (DC) types
63
. The SV-40 large 
T nuclear localisation signal peptide, containing a fluorescein 
(flu) tag at its C terminus for confirmation of attachment, was 
bound to 40 nm AuNPs via a cysteine linker and used to probe 
SH-SY5Y cells with 633 nm excitation, producing cellular maps 
at a resolution of 200 x 600 nm per pixel. Unambiguous 
characterisation of DC and undifferentiated cells (UDCs) was 
achieved through principal component analysis (PCA) across 
both the whole cell and the nuclear region. Furthermore, 
characterisation of cell differentiation was carried out by 
examination of nuclear regions, which undergo changes in 
ratios of molecular content as well as morphological and 
structural development
163
. Reorganisation of chromatin plays 
an important role in the proliferation of non-dividing cells 
(DCs) which maintain a steady molecular formation relative to 
UDCs whose nuclear regions undergoes continuous changes in 
chromatin formation during mitosis. The acquired SERS data 
revealed a shift towards increased ratio of DNA/RNA in DCs 
relative to UDCs, as revealed by respective characteristic peak 
intensities. The number of protein peaks detected in DCs was 
also increased, indicating greater expression and variety of 
protein within the nuclear region
63
. This characterisation of 
cellular differentiation exhibits not only the ability of reporter-
free SERS to distinguish between cell phenotypes but also how 
the careful application of statistical analysis methods such as 
PCA are utilised to effectively reduce the complex data 
matrices to unambiguously achieve classification. 
  More recent work by the same group further effectively 
demonstrated chemometric analysis in combination with 
tailored sample preparation to achieve detailed hyperspectral 
characterisation of endosomes and lysosomes in the 
endolysosomal pathway in SH-SY5Y cells
64
. The novel method 
for creation of a reference state depicted in Fig. 7 was derived 
from a conventional pulse-chase technique
16,67
, whereby cells 
were subjected to a 72 h AuNP incubation pulse to ensure a 
wide distribution of the AuNPs within various types of vesicle 
and achieve high SERS signal. Cells analysed in this state were 
assigned as the sample group (n= 20). A reference state (n=14) 
was generated by carrying out the same incubation phase 
followed by a 48 h depletion phase in which the extracellular 
fluid was removed and replaced with fresh, AuNP-free media 
to ensure that the nanoprobes were processed through the 
endolysosomal system and only localised within lysosomes. 
Background subtraction of the generated SERS map data with 
principal component (linear summations of original data 
multiplied by a coefficient that describes the generated 
principle components, PCs) scores lower than 25% of the 
maximal PC1 value (Fig. 8A). PCA-LDA (Linear Discriminant 
Analysis) allows for the transformation of PC data to achieve 
maximum class segregation by hyperspectral peak positions, 
ratios and intensities. This was employed to assign PCA-LDA 
scores (Fig. 8C) as lysosomes (blue, scores common to both 
sets) or endosomes (green, scores exclusive to the reference 
state) with borderline case exclusion. Exemplarily, the back-
projected pseudo colour map of the LD scores (Fig. 8D) clearly 
depicted the localisation of each vesicle type in a single cell, 
showing broad agreement with the supervised, multivariate 
analysis technique k-means clustering (Fig. 8E).  
  Furthermore, characterisation of endosomes and lysosomes 
was achieved by observation of PC1 loadings, which were 
weighted with individual peak probabilities to reveal subtle 
differences in molecular content. These variations identified 
molecular processes occurring along the endolysosomal 
pathway as the breakdown of proteins and lipids, progressively 
raised acidity, and degradation of DNA/RNA in lysosomes
64
.  
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  The avenues by which the successful implementation of this 
tailored preparation and reference-based PCA-LDA based 
method address the shortcomings of label-free SERS 
experiments are multifaceted. Firstly, the technique not only 
allows for extraction of useful data from the complex and large 
original dataset, but also provides an improvement on existing 
analysis methods such as standard PCA-LDA (Fig. 8B) and the k-
means clustering used for validation in this study. Creation of 
the reference state provides a physical meaning to classes, and 
hence spectral assignments, whereas k-means itself does not 
allow unambiguous assignment of clusters to speciﬁc classes 
such as endosomes and lysosomes. The method was also 
veriﬁed on negative controls (cells with lysosomes only) and 
the classiﬁcation was not only accurate but also demonstrated 
an advantage over single frequency SERS and simple LD score 
maps. Mean centring and PCA steps also address the issue of 
heterogeneous SERS enhancements by uncontrollable NP 
aggregation
64
.  
  Intracellular and label-free SERS has also been utilised in 
elucidating the biomolecular dynamics of the stress response 
to UV-C (254 nm) irradiation in HSC-3 cells
164
. NLS and RGD 
targeted Au nanocubes observed damage to cytosolic proteins 
containing sulphur and aromatic amino acids and changes to 
their secondary structure. The 502 cm
-1
 disulfide vibrational 
mode exhibited decreased intensity compared to that of the C-
S 653 cm
-1
 mode during irradiation which reflected the 
photolytic cleavage of disulphide bonds. The UV-C exposure 
was also determined to completely arrest NP transport within 
living cells and induce apoptosis, hallmarked by intense 
vibrations at 1000 and 1584 cm
-1
. Real-time evaluation of 
defence mechanisms of cancerous cells towards UV exposure 
is a valuable application of label-free SERS in forwarding 
photothermal therapies
164
. 
  As mentioned earlier, the uniformity of SERS signals is extremely 
significant for reporter-free SERS, in particular for quantitative 
analysis. Considerable efforts have been made into 
counteracting the uncontrollable aggregation of internalised 
AuNPs by adaptation and modification of the particle 
structure.  The production of gold lace nanoshells not only 
generates high SERS enhancements in the 1-3 nm hotspots 
between branch like structures (3-5 nm) without aggregation, 
but also offers further application as a model for the delivery 
and monitoring of hydrophobic drugs
85
. The topology 
generated by surfactant mediated production from 
polyurethanes (PUs) is similar to that of a Faberge egg, with 
the hydrophobic core (used to cargo drugs) provided the 
amphiphilic structure of PU globules. SERS monitoring of 
loaded pyrene was carried out, the release of which was 
shown to plateau out after 30 h. The lace nanoshells offer 
tighter synthetic control of diameter relative to 
thermosensitive polymer gold cages
88
 and liposome-gold 
nanocontainers
86
 also used for hydrophobic drug delivery.  
This aids avoidance of first capture by macrophages and renal 
clearance when carriers are too large or small respectively. The 
improved homogeneity of hotspots offers advantage in 
generating reproducible label-free SERS measurements over 
spherical NPs
85
.  
  Similarly, the top-down construction of gold nanostructured 
microchips proposes an alternative means of removing the 
variability inherent to reporter-free SERS by aggregating 
spherical NPs. Chips with a uniform and reproducible 
nanodome gold pattern were generated by nanosphere 
lithography, depositing a gold nanofilm on a monolayer of 
polystyrene bead templates and thereafter released into 
solution
87
. Like spherical NPs, the microchips were taken up by 
normal human dermal fibroblast (NHDF) cells with no 
suggestion of reduced viability from observation of mitotic 
events. A proof-of-concept detection experiment was then 
carried out using the common extraneous SERS molecule, 
rhodamine 6G (R6G). Following a 24 h incubation period, the 
intracellular location of the microchips and inhomogeneous 
Figure 8: Demonstration with a test sample cell of different analysis steps and 
comparisons. Bright-field image (A) highlights the scanned area resulting in the 
corresponding absolute SERS intensity map (B). Pseudo colour PC1 intensity map (C) 
of the same cell after PC analysis shows the sample background as white for PC1 
scores values smaller 0.25. LD1 scores map (D) of the sample cell prior to 
endosomes/lysosomes classification. (E) Assignment of components from the LD1 
scores intensity distribution to either lysosomes (LD1(s) > -0.35) or endosomes 
(LD1(s) < -0.45) highlighted in blue and green, respectively. Assignments were made 
with respect to the modes μ1(ref) and μ2(s) as well as the standard deviations 
σ1(ref) and σ2(s) marked as dotted lines. The light grey region between the green 
and blue regions is a transition region to guarantee an accurate classification. (F) 
Based on scores for respective class assignments derived from (E), scores were 
projected back into a false-colour map. This generates a color-coded reference-
based PCA-LDA map showing endosomes (green) and lysosomes (blue). (G) A colour 
map was reconstructed after k-means clustering of the test data set for the three 
groups (white, grey, black) confirming the group segregation facilitated using our 
color-coded reference-based PCA-LDA method. Scale bars: 10 μm, (C-D) and (F-G) 
pixel size: 600 nm x 600 nm. Reprinted with permission from A. Huefner, W.-L. Kuan, 
K. H. Müller, J. N. Skepper, R. A. Barker and S. Mahajan, ACS Nano, 2015. Copyright 
2015 ACS Nano. 
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distribution of R6G were confirmed in NHDF cells by confocal 
reflection and fluorescence microscopy (Fig. 9). The 
transmission image reveals the location of the cell which was 
mapped for the 1365 cm
−1
 R6G SERS peak (imaged in green). 
  This successful detection of a well-established SERS-active 
compound using nanostructured microchips paves the way for 
detection of extraneous molecules within live cells with 
improved reproducibility due to relative homogeneity of 
hotspot enhancements. This study also partially addressed a 
previous difficulty in determining of the exact location of 
internalised AuNPs, given that voluntarily internalised NPs 
exist in membrane-bound transport vesicles from which they 
may or may not escape to be free in the cytosol. A lack of co-
localisation of the microchips with fluorescent dyes 
LysoTracker Red DND-99 and Vybrant Dil (accumulating in 
acidic cellular components and lipophilic membranes 
respectively) suggested no localisation within vesicles of the 
endocytotic pathway, although further studies are required to 
verify exact location. Despite protein corona adsorption to the 
gold plated chips forming an extra barrier for molecules to 
cross to reach plasmonic hotspots, this novel and label-free 
approach takes positive steps towards homogenously 
enhanced, time-dependent and quantitative detection of 
intracellular molecules by SERS
87
.   
  Recently, in a powerful combination, reporter-free SERS and 
SERS reporter nanoprobes were employed by Chen et al. to 
simultaneously image the nucleus and plasma membrane of 
single HeLa cells in three dimensions, afforded by confocal 
SERS microscopy
65
. Characterisation of the nucleus and 
tracking of time dependent changes in molecular constitution 
during induced apoptosis was achieved using NLS-
functionalised, reporter-free AuNPs. Consequently, slow 
condensation and degradation of chromatin, nuclear rupture 
and denaturation and degradation of proteins were all 
identified. AuNP-bound Raman dyes 4-MBA, Crystal Violet and 
Cresyl Violet acetate were used as SERS reporters to monitor 
the localisation and detachment of folate and luteinizing 
hormone-releasing hormone receptors in real time. The SERS 
reporter portion of this investigation provided verification that 
specific endogenous molecules are being monitored, which is 
sometimes an ambiguity in purely reporter-free studies. 
Although a fairly laborious process, the combination of 
reporter and reporter-free SERS techniques displays great 
promise for in situ characterisation of complex intracellular 
processes, with application of suitable chemometric analysis
65
. 
Conclusions and Outlook 
  As a non-destructive, highly sensitive technique capable of 
sub-micron imaging resolutions, SERS holds immense potential 
for interrogation of the intracellular environment across 
biomedical research. Acquisition times can be optimised down 
to the sub-millisecond range, sufficient for even single 
molecule detection
11,13,165
. Under appropriate laser powers, 
absence of signal deterioration effects such as photobleaching 
of samples allows for live cell investigations. Despite a 
requirement for standardisation of toxicity studies
114
, the 
employed nanostructures - particularly those of gold - appear 
not to impinge upon the viability of live cells. Intracellular SERS 
studies are still in their infancy; however, this is a fast-paced 
field attracting high levels of interest with an ever-growing 
body of research. Advances in nanotechnology have led to an 
increasingly varied library of SERS active structures, tailored to 
addressing the difficulties of in cellulo experiments such as 
cellular entry, pH dependent aggregation and targeting of 
specific compartments.  
  It is clear that the choice of intracellular SERS experiment 
performed is very dependent on not only the studied system 
but also the data required. SERS reporter methodology 
benefits greatly from simplicity of data analysis, and holds 
advantage over fluorescence microscopy in increased spectral 
resolution to allow multiplexing of a larger number of unique 
optical signatures. The discussed studies offer reporter-based 
SERS as an effective tool for the imaging of molecules and 
proteins with known vibrational signatures, as well as 
relatively simple quantification of simple cellular 
Figure 9: Reporter-free intracellular detection of Rhodamine-6G. (A) Confocal fluorescence scan of a single cell with several nanodome-patterned microchips show the 
intracellular localisation of the microchips, as well as the uptake and inhomogeneous distribution of R6G in the cell. (B) Transmission image of the same cell, where SERS spectra 
are mapped over the region marked with a red square. The inset shows the integrated number of counts in the 400–1700 cm
−1 
region (graded red-yellow), on top of which the 
presence of the 1365 cm
−1 
R6G-peak is highlighted in green, which corresponds to the green shaded area in (C). (C) SERS spectra on different positions of the microchip show the 
intracellular SERS detection of R6G (middle, green) and the R6G reference SERS spectrum (bottom, blue), while other positions show the presence of peaks related to other 
molecules adsorbed on the microchip (dotted red, top). Spectra are normalized and offset for clarity. Reprinted with permission from P. C. Wuytens, A. Z. Subramanian, W. H. De 
Vos, A. G. Skirtach and R. Baets, The Analyst, 2015- Published by The Royal Society of Chemistry. 
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processes
131,132,137
. The approach has matured to therapeutic 
application with multipurpose nanostructures which not only 
detect and monitor but deliver a cargo of hydrophobic drug 
molecules into intracellular compartments
62
.  
  Despite being less widely developed; label-free SERS is more 
suited as a powerful means of probing complex cellular 
processes due to the sheer wealth of information which can be 
extracted from a single measurement of the intracellular 
matrix about the vicinity of the NP.  This however comes at the 
cost of throughput times, as careful processing and analysis of 
experimental data must be employed to extract desired 
information in order to accurately and unambiguously 
characterise processes at the molecular level. Such 
methodology was effectively achieved in the cases of 
endocytosis and apoptosis
64,65
. Combination of label-free and 
SERS reporter techniques yields comprehensive findings, 
tracking both the localisation of specific proteins as well as 
monitoring changes in the diverse chemical environment. 
Tailoring of sample preparation to create a sample set   upon 
which to train multivariate analysis methods such as PCA-LDA 
prove equally capable with the potentially complex synthesis 
of multiple functionalised SERS reporter probes. In either case, 
it remains that the development of statistical methodologies 
and data analysis toolkits are central to potentiating the use of 
reporter-free SERS to deconvolute the molecular dynamics of 
intracellular structures, pathways and processes.  
  Future developments in intracellular SERS will be of particular 
interest to the pharmaceutical industry, for elucidating new 
drug targets in both healthy and pathogenic cells through cell-
based assays. Additionally, there exists a requirement for 
determination of administered small molecules concentration 
and localisation at the sub cellular level, which no established 
technology can currently satisfy
166
. Without information on 
whether candidates are entering cells, let alone localising to 
and interacting with target organelles or biomolecules, 
pharmacodynamics cannot be fully understood which 
contributes to the lack of in vivo efficacy responsible for the 
failure of a large portion of clinical trials
166
. Microfluidics, both 
for nanoprobe synthesis and cellular interrogation will also 
play a major role in the development of tightly controlled, 
reproducible and ultimately higher throughput techniques. 
Along with early-stage diagnostics by SERS-reporter and 
reporter-free SERS methodologies, these applications should 
form central goals for future proof-of-concept, assay 
development and process optimisation studies in order to 
further develop and implement highly powerful intracellular 
SERS techniques for interrogation of the cellular environment. 
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